CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS. Elkins J, Sheridan J, Amaravadi L, Riester K, Selmaj K, Bielekova B, Parr E, Giovannoni G Neurol Neuroimmunol Neuroinflamm. 2015 Apr; 2(2):e65. Epub 2015 Jan 22. PMID: 25635261. Abstract CommentRecommendBookmarkWatch